FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

56085009: Hyoscyamine sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
93277011 Hyoscyamine sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
497507010 Hyoscyamine sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
794558011 Hyoscyamine sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
816941000172113 sulfate d'hyoscyamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscyamine sulfate Is a Product containing hyoscyamine (medicinal product) false Inferred relationship Some
Hyoscyamine sulfate Is a Hyoscyamine (substance) false Inferred relationship Some
Hyoscyamine sulfate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Muscarinic receptor antagonist (disposition) true Inferred relationship Some
Hyoscyamine sulfate Is a Muscarinic receptor antagonist true Inferred relationship Some
Hyoscyamine sulfate Is a Antispasmodic (substance) true Inferred relationship Some
Hyoscyamine sulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Hyoscyamine (substance) true Inferred relationship Some
Hyoscyamine sulfate Is a Antiparkinsonian agent (substance) false Inferred relationship Some
Hyoscyamine sulfate Is a Tropane alkaloid (substance) true Inferred relationship Some
Hyoscyamine sulfate Is a Naturally occurring alkaloid (substance) true Inferred relationship Some
Hyoscyamine sulfate Is a Acetylcholine receptor antagonist false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Hyoscyamine sulfate 0.031mg/1 mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Hyoscyamine sulfate 0.5mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Hyoscyamine sulfate 375 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Hyoscyamine sulfate 0.125mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Product containing precisely hyoscyamine sulfate 125 microgram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Product containing atropine sulfate and hyoscyamine sulfate and scopolamine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some
Hyoscyamine sulfate dihydrate (substance) Is a False Hyoscyamine sulfate Inferred relationship Some
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some 3
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Hyoscyamine sulfate Inferred relationship Some 3
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate 375 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate 375 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate dihydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Hyoscyamine sulfate Inferred relationship Some
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate 375 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Hyoscyamine sulfate Inferred relationship Some 3
Product containing precisely hyoscyamine sulfate 125 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely hyoscyamine sulfate 125 microgram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate 25 microgram/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 1
Hyoscyamine sulfate 25 microgram/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Hyoscyamine sulfate Inferred relationship Some 2
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Hyoscyamine sulfate Inferred relationship Some 2
Hyoscyamine sulfate anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Hyoscyamine sulfate Inferred relationship Some

This concept is not in any reference sets

Back to Start